208 related articles for article (PubMed ID: 21422808)
1. Differential recognition of viral RNA by RIG-I.
Baum A; García-Sastre A
Virulence; 2011; 2(2):166-9. PubMed ID: 21422808
[TBL] [Abstract][Full Text] [Related]
2. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing.
Baum A; Sachidanandam R; García-Sastre A
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16303-8. PubMed ID: 20805493
[TBL] [Abstract][Full Text] [Related]
3. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.
Yoshida A; Kawabata R; Honda T; Sakai K; Ami Y; Sakaguchi T; Irie T
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237838
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.
Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB
mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454
[TBL] [Abstract][Full Text] [Related]
5. PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.
Ho TH; Kew C; Lui PY; Chan CP; Satoh T; Akira S; Jin DY; Kok KH
J Virol; 2016 Feb; 90(3):1557-68. PubMed ID: 26608320
[TBL] [Abstract][Full Text] [Related]
6. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.
Martínez-Gil L; Goff PH; Hai R; García-Sastre A; Shaw ML; Palese P
J Virol; 2013 Feb; 87(3):1290-300. PubMed ID: 23175362
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of RIG-I-mediated innate antiviral signaling by SEC14L1.
Li MT; Di W; Xu H; Yang YK; Chen HW; Zhang FX; Zhai ZH; Chen DY
J Virol; 2013 Sep; 87(18):10037-46. PubMed ID: 23843640
[TBL] [Abstract][Full Text] [Related]
8. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
[TBL] [Abstract][Full Text] [Related]
9. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins.
Strähle L; Marq JB; Brini A; Hausmann S; Kolakofsky D; Garcin D
J Virol; 2007 Nov; 81(22):12227-37. PubMed ID: 17804509
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
Liu G; Lu Y; Liu Q; Zhou Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
[TBL] [Abstract][Full Text] [Related]
11. RNase L Amplifies Interferon Signaling by Inducing Protein Kinase R-Mediated Antiviral Stress Granules.
Manivannan P; Siddiqui MA; Malathi K
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295917
[TBL] [Abstract][Full Text] [Related]
12. Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.
Sánchez-Aparicio MT; Garcin D; Rice CM; Kolakofsky D; García-Sastre A; Baum A
J Gen Virol; 2017 Jun; 98(6):1282-1293. PubMed ID: 28631605
[TBL] [Abstract][Full Text] [Related]
13. Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.
Mercado-López X; Cotter CR; Kim WK; Sun Y; Muñoz L; Tapia K; López CB
Vaccine; 2013 Nov; 31(48):5713-21. PubMed ID: 24099876
[TBL] [Abstract][Full Text] [Related]
14. Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.
Mura M; Combredet C; Najburg V; Sanchez David RY; Tangy F; Komarova AV
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768856
[TBL] [Abstract][Full Text] [Related]
15. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
[TBL] [Abstract][Full Text] [Related]
16. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.
Patel JR; Jain A; Chou YY; Baum A; Ha T; García-Sastre A
EMBO Rep; 2013 Sep; 14(9):780-7. PubMed ID: 23846310
[TBL] [Abstract][Full Text] [Related]
17. Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction.
Liu G; Park HS; Pyo HM; Liu Q; Zhou Y
J Virol; 2015 Jun; 89(11):6067-79. PubMed ID: 25810557
[TBL] [Abstract][Full Text] [Related]
18. ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner.
Yang YK; Qu H; Gao D; Di W; Chen HW; Guo X; Zhai ZH; Chen DY
J Biol Chem; 2011 Mar; 286(12):10568-80. PubMed ID: 21233210
[TBL] [Abstract][Full Text] [Related]
19. RIG-I ATPase activity and discrimination of self-RNA versus non-self-RNA.
Anchisi S; Guerra J; Garcin D
mBio; 2015 Mar; 6(2):e02349. PubMed ID: 25736886
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway.
Minamitani T; Iwakiri D; Takada K
J Virol; 2011 Apr; 85(8):4035-40. PubMed ID: 21248047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
